Monday, April 7, 2008

Nestle Novartis Pays $11 Billion for Stake in Nestle's Alcon (Update6)

Smart move - by selling off 25% of Alcon the maker of Opti-Express, Nestle who no longer sees Alcon as profitable will use proceeds from the sale to reduce debt and expand its nutritional foods division.

1 comment:

L Wilder said...

Nestle looked at the long term strategic planning and recognized that Alcon was not a good investment. Using the sales to pay off debt and expand its empire to invest in other products is a wise move. Nestle does not let grass grow under its feet.